| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |